Physician

Mykhanh Connie Nguyen, M.D.

According to 2025 Medicare claims, Mykhanh Nguyen, M.D. (NPI: 1508820606) practices radiation oncology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236.

Nguyen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 470 traditional Medicare patients, billed 10,666 HCPCS/CPT codes, and received $1,784,902 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 307 prescription claims across 120 beneficiaries totaling $6,286 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2022 DME data shows 31 claims. Open Payments data shows 35 records totaling $7,494. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,737 and ending at $6,286. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $50 and ending at $605.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	394	21,829	$1,875,435
2016	645	27,548	$1,718,899
2017	741	25,140	$1,708,973
2018	657	14,914	$1,059,866
2019	582	13,544	$1,127,241
2020	560	10,263	$1,078,318
2021	568	8,274	$1,023,738
2022	603	13,591	$1,419,605
2023	534	12,220	$1,197,429
2024	470	10,666	$1,784,902

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	278	$7,737
2016	137	294	$13,293
2017	115	207	$5,448
2018	109	193	$5,423
2019	88	155	$6,381
2020	109	230	$7,388
2021	121	260	$11,005
2022	136	294	$10,722
2023	136	298	$5,447
2024	120	307	$6,286

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	29	$2,504
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	37	$4,378
2019	N/R	58	$8,052
2020	N/R	41	$6,033
2021	N/R	58	$7,207
2022	N/R	31	$4,685
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	195	1,123	$242
77427	Radiation treatment management, 5 treatment sessions	123	310	$139
77014	Ct guidance for insertion of radiation therapy fields	209	1,146	$84
77336	Continuing radiation therapy consultation per week	173	296	$61
77300	Calculation of radiation therapy dose	117	242	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	392	$806
Dexamethasone	Dexamethasone	21	346	$521
Lidocaine Hcl Viscous	Lidocaine Hcl	13	198	$480
Tamsulosin Hcl	Tamsulosin Hcl	14	424	$365
Levothyroxine Sodium	Levothyroxine Sodium	23	1,683	$341

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$7,494	Elekta, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mykhanh Connie Nguyen, M.D.?

Tedicare shows public-source Medicare data for Mykhanh Connie Nguyen, M.D. (NPI 1508820606), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mykhanh Connie Nguyen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mykhanh Connie Nguyen, M.D.?

Mykhanh Connie Nguyen, M.D. is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Mykhanh Connie Nguyen, M.D. have Open Payments data?

Mykhanh Connie Nguyen, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.